Thus, despite the enhanced activation of the NRF2-xCT axis might efficiently preserve the redox homeostasis of BC cells under OS, it might also decrease their metabolic flexibility, unveiling a specific vulnerability that can be therapeutically exploited [252]. Here, NFE2L2 is linked to breast cancer.